Abstract

The Problem of Drug Diversion

Author(s): Burke John J

Issue: Jan/Feb 2002 - Compounding for Pain Management and Dental Medicine

Page(s): 11-12

Download in electronic PDF format for $75

Abstract

This discussion, by a commander of the Warren County Drug Task Force in Lebanon, OH, and the vice president of the National Association of Drug Diversion Investigators, covers the most frequently abused pharmaceuticals in the United States and avenues of health-care fraud. The author concludes that reducing prescription drug abuse is the responsibility of the physician, pharmacist and law enforcement officials and that these professionals must cooperate to identify and eliminate such addiction.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Jan/Feb 2002 Pg. 11-12	The Problem of Drug Diversion Author(s): Burke John J
Jan/Feb 2002 Pg. 13-15	Providing Analgesia and Curtailing Drug Diversion: A Pharmacist's Perspective Author(s): Vail Jane
Jan/Feb 2020 Pg. 30-36	Quality Control: Personal Protective Equipment for Use When Handling Hazardous Drugs Author(s): Dillon L R
Sep/Oct 2017 Pg. 356	PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs Author(s): Allen Loyd V Jr
Nov/Dec 2011 Pg. 526-527	PostScription: Drug Disposal: Compounding Pharmacists' Involvement in the Prevention of Prescription Drug Misuse and Abuse Author(s): Williams LaVonn A
May/Jun 2016 Pg. 202-206	Does Your Drug Expertise Include Clinical Pharmaceutics? Author(s): Newton David W
Jul/Aug 2012 Pg. 294-298	Drug Shortages & Discontinued Drugs: The Effects on Patients and Healthcare Providers Author(s): Allen Loyd V Jr, Williams LaVonn A
Mar/Apr 2011 Pg. 92	PreScription: Discontinued Drugs and Drug Shortages Author(s): Allen Loyd V Jr
Nov/Dec 2012 Pg. 456-460	Drug Shortage Compounding: The Only Safe Medication Source in a Time of Crisis Author(s): Lyon Joanna
Jul/Aug 2016 Pg. 351 View Sample	Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines Author(s): Allen Loyd V Jr
Jul/Aug 2022 Pg. 298-301	The Role of Compounding Pharmacists During Drug Shortages Author(s): Ofei Kelvin
Nov/Dec 2015 Pg. 487-488	U.S. Food and Drug Administration "Evaluation Criteria" for Difficult to Compound Drugs Author(s): Allen Loyd V Jr
Mar/Apr 2018 Pg. 108-121	Personalized Medicine and Customized Drug Delivery Systems: The New Trend of Drug Delivery and Disease Management Author(s): Soni Abhishek, Gowthamarajan Kuppusamy, Radhakrishnan Arun
Jul/Aug 2012 Pg. 350-351	PostScription: Drug Shortages and Discontinued Drugs: Their Effects on Healthcare Author(s): Allen Loyd V Jr, Williams LaVonn A
Jul/Aug 2002 Pg. 271-273	Gaining Access to Investigational Drug for Treatment: An Investigational New Drug Application Primer Author(s): Kramer Mark A, Grilley Bambi J
Mar/Apr 2004 Pg. 101-105	Pluronic Lecithin Organogel for Local Delivery of Anti-Inflammatory Drugs Author(s): Frankum James, Ramsay Dale, Das Nandita G, Das Sudip K
May/Jun 2006 Pg. 175-183	The Role of Drug Promotion in the Prescription of Hormone Replacement Therapy in the United States Author(s): Stephenson Kenna, Jones William, Stephenson Douglas M M
Jul/Aug 2018 Pg. 268	PreScription: Factors Related to Drug Waste and Pharmacy Solutions Author(s): Allen Loyd V Jr
Sep/Oct 2014 Pg. 379-380	Final Guidance for Pharmacy Compounding of Human Drug Products Under Section 503A Author(s): Blankenship Cynthia E
Sep/Oct 2015 Pg. 377-380	The Evolution of 21 CFR Parts 210 & 211 for Drug Compounders: An Unspoken Opportunity for Pharmacists Author(s): Parks Kenneth Chase, Bernard Brian, Cogdill Christopher Blake